UA73341C2 - Method for manufacturing injectional dosage forms of drugs based on ?-lipoic acid - Google Patents

Method for manufacturing injectional dosage forms of drugs based on ?-lipoic acid

Info

Publication number
UA73341C2
UA73341C2 UA2002086747A UA2002086747A UA73341C2 UA 73341 C2 UA73341 C2 UA 73341C2 UA 2002086747 A UA2002086747 A UA 2002086747A UA 2002086747 A UA2002086747 A UA 2002086747A UA 73341 C2 UA73341 C2 UA 73341C2
Authority
UA
Ukraine
Prior art keywords
lipoic acid
injectional
manufacturing
dosage forms
glycol
Prior art date
Application number
UA2002086747A
Inventor
Filia Ivanivna Zhebrovska
Maryna Illinichna Borschevska
Olha Mykolaivna Oleksiichuk
Original Assignee
Farmac Open Joint Stock Compan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmac Open Joint Stock Compan filed Critical Farmac Open Joint Stock Compan
Priority to UA2002086747A priority Critical patent/UA73341C2/en
Publication of UA73341C2 publication Critical patent/UA73341C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the pharmacy, in particular to the technology for manufacturing injectional dosage forms of the drugs used for preventing andtreating the coronary atherosclerosis, liver diseases, the diabetic polynephropathy, or intoxication. The method comprises mixing a-lipoic acid with organic amine, glycol, and the water for injection. N-methyl glucamine is used as an organic amine, and polyethylene glycol (PEG) is used as a glycol. According to the invention, first PEG and a-lipoic acid are mixed, and then N-methyl glucamine is added. Finally, the water for injection is added to the mixture. The specified ratio of the initial components is used for the manufacture.
UA2002086747A 2002-08-14 2002-08-14 Method for manufacturing injectional dosage forms of drugs based on ?-lipoic acid UA73341C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2002086747A UA73341C2 (en) 2002-08-14 2002-08-14 Method for manufacturing injectional dosage forms of drugs based on ?-lipoic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2002086747A UA73341C2 (en) 2002-08-14 2002-08-14 Method for manufacturing injectional dosage forms of drugs based on ?-lipoic acid

Publications (1)

Publication Number Publication Date
UA73341C2 true UA73341C2 (en) 2005-07-15

Family

ID=34884613

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2002086747A UA73341C2 (en) 2002-08-14 2002-08-14 Method for manufacturing injectional dosage forms of drugs based on ?-lipoic acid

Country Status (1)

Country Link
UA (1) UA73341C2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA012378B1 (en) * 2008-10-14 2009-10-30 Екофарм Патент Менеджмент Аг 1-deoxy-1-n-methyl ammonium-d-glucitol succinate
RU2451511C1 (en) * 2010-11-19 2012-05-27 Филя Ивановна Жебровская Method for production of injection form of alpha-lipoic acid based preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA012378B1 (en) * 2008-10-14 2009-10-30 Екофарм Патент Менеджмент Аг 1-deoxy-1-n-methyl ammonium-d-glucitol succinate
RU2451511C1 (en) * 2010-11-19 2012-05-27 Филя Ивановна Жебровская Method for production of injection form of alpha-lipoic acid based preparation

Similar Documents

Publication Publication Date Title
DE60104340D1 (en) Process for the preparation of drug-loaded polymer micelle composition
ATE493133T1 (en) ANTIBIOTIC/ANALGESIC FORMULATION AND METHOD FOR PRODUCING SUCH FORMULATION
WO2007084460A8 (en) Pharmaceutical compositions with enhanced stability
ATE228828T1 (en) METHOD FOR PRODUCING SOLID DOSAGE FORMS CONTAINING CYCLODEXTRIN
BRPI0409185A (en) topical anthelmintic veterinary formulations
ATE410459T1 (en) BIODEGRADABLE POLYKETALS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
ATE355829T1 (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING A LIPOPHILIC ACTIVE INGREDIENT AND THE PRODUCTION THEREOF
DK1284716T3 (en) Self-emulsifying active ingredient formulation and use of this formulation
TW200640500A (en) Process for the production of an abuse-proofed dosage form
DE602005018387D1 (en) MEDICAL COMPOSITION, PROCESS FOR YOUR HDI-HYDROPYRIDINE COMPOUND IN A MEDICAL COMPOSITION
WO2007072161A3 (en) Fertilizer
ATE409050T1 (en) METHOD FOR PRODUCING TWO- AND THREE-DIMENSIONAL POLYMER SCRAFTS
DK1563041T3 (en) Use of 2,6-di-tert-butyl-β-cresol to increase the storage stability of biodiesel
DK1608346T3 (en) Drug delivery compositions of alpha-hydroxy acid ester and methods of use thereof
MX2007014830A (en) Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients.
ATE293595T1 (en) THYROID HORMONE ANALOGUES AND METHOD FOR THE PRODUCTION THEREOF
UA73341C2 (en) Method for manufacturing injectional dosage forms of drugs based on ?-lipoic acid
DE60130575D1 (en) PROCESS FOR THE PREPARATION OF ACYLPHENYL ALANINES
ATE526988T1 (en) METHYLPHENIDATE SOLUTION AND RELEVANT ADMINISTRATION AND MANUFACTURING METHODS
BR0300698A (en) Quinazoline derivatives, a process for their preparation and pharmaceutical compositions containing them
ATE298567T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING IBUPROFEN AND A METHOD FOR THE PRODUCTION THEREOF
WO2008033058A3 (en) Method for producing insulin in the form of an oral preparation
HK1126790A1 (en) Biologically active peptide vapeehptllteaplnpk derivatives
DE602004032265D1 (en) METHOD OF MANUFACTURING MEDICAL COMPOSITIONS
WO2003099218A3 (en) Anti-cancer formulation